Skip to main content

Table 3 Demographics, clinical and tumor characteristics at diagnosis, surgical data, and oncological outcomes for women 18–40 years old who either had or had not given birth after undergoing FSS for epithelial ovarian cancer in Sweden 2008–2015

From: A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women

  Given Birth After FSS Not Given Birth After FSS P-value
N (%) 9 (25) 27 (75)  
Mean age, years (range) 28 (23–37) 29 (19–39) 0.626
Previous parity, n (%)
 0 5 (56) 22 (81) 0.133
 1 3 (33) 3 (11)  
 2 1 (11) 1 (4)  
 ≥ 3 0 0  
FIGO stage, n (%)
 IA 5 (56) 22 (81) 0.184
 IB  
 IC 4 (44) 5 (19)  
IC1 4 2  
IC2   3  
IC3  
Histologic type, n (%)
 Serous, high-grade   2 (7)  
 Serous, low-grade 1 (11)   
 Mucinous 4 (44) 14 (52)  
 Endometrioid 4 (44) 6 (22)  
Grade 1 3 3  
Grade 2   2  
Grade 3 1  
Clear cell 0 3  
Other a 0 2  
Surgical mode,b n (%)
 Open 6 (67) 21 (78) 0.335
 Laparoscopy 3 (33) 3 (11)  
 Robot 0 3 (11)  
Type of surgery, n (%)
 Primary 4 (44) 13 (48)  
 Re-staging 5 (56) 14 (52)  
Type of staging procedure, n (%)
 Cytology 8 (89) 22 (82)  
 Peritoneal biopsies 9 (100) 27 (100)  
 Oment 6 (67) 20 (74)  
 LN pelvic 1 (11) 2 (7)  
 LN paraaortic 1 (11) 3 (11)  
Adjuvant chemotherapy, n (%) 4 (44) 9 (33) 0.693
Histologic review,c
n (%)
8 (89) 25 (93) 1.00
Recurrence, n (%) 0 2 (7)  
Died of disease, n (%) 0 1 (4)  
Follow-up, months, mean (range) 75 (44–111) 56 (16–99) 0.04